AD risk factors, such as stroke or head injury involve glutamate receptor-mediated excitotoxicity and impact Ca2+ signalling in a way which mechanistically resembles Aβo-instigated activation of Erk1/2 by NMDA receptors. This evidence concerns the gene ABO and Alzheimer disease.